Medicinova MNOV
NASDAQ MNOV
$1.78 +0.15 (+9.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Medicinova (MNOV) Gains from Sales and Divestitures (2010 - 2024)

Updated

Medicinova (MNOV) reported Gains from Sales and Divestitures of -$1.00 for Q4 2024, compared with -$101.00 a year earlier.

Analysis

Medicinova (MNOV) Gains from Sales and Divestitures (2010 - 2024) Analysis & Trends

For FY2024, Medicinova posted Gains from Sales and Divestitures of $198.00.

  • By year, Gains from Sales and Divestitures came in at -$472.00 in FY2023 and -$286.00 in FY2021.
  • The Q4 2024 figure ranks as the highest quarterly Gains from Sales and Divestitures since Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Medicinova 87.61 Mn 87.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.00
Dec 31, 2023 -101.00
Dec 31, 2013 -493.00
Mar 31, 2013 4,800.00
Dec 31, 2010 3,386.00
API Access

Medicinova Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MNOV&period=max&api_key=YOUR_API_KEY